Literature DB >> 19223554

Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages.

Tim D Eubank1, Ryan D Roberts, Mahmood Khan, Jennifer M Curry, Gerard J Nuovo, Periannan Kuppusamy, Clay B Marsh.   

Abstract

Tumor-educated macrophages facilitate tumor metastasis and angiogenesis. We discovered that granulocyte macrophage colony-stimulating factor (GM-CSF) blocked macrophages vascular endothelial growth factor (VEGF) activity by producing soluble VEGF receptor-1 (sVEGFR-1) and determined the effect on tumor-associated macrophage behavior and tumor growth. We show GM-CSF treatment of murine mammary tumors slowed tumor growth and slowed metastasis. These tumors had more macrophages, fewer blood vessels, and lower oxygen concentrations. This effect was sVEGFR-1 dependent. In situ hybridization and flow cytometry identified macrophages as the primary source of sVEGFR-1. These data suggest that GM-CSF can re-educate macrophages to reduce angiogenesis and metastases in murine breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223554      PMCID: PMC2722508          DOI: 10.1158/0008-5472.CAN-08-1405

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Tumour-educated macrophages promote tumour progression and metastasis.

Authors:  Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

3.  Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.

Authors:  Katrin Lamszus; Ulrike Ulbricht; Jakob Matschke; Marc A Brockmann; Regina Fillbrandt; Manfred Westphal
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

Review 4.  Cytokine control of developmental programs in normal hematopoiesis and leukemia.

Authors:  Joseph Lotem; Leo Sachs
Journal:  Oncogene       Date:  2002-05-13       Impact factor: 9.867

5.  Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer.

Authors:  Masakazu Toi; Hiroko Bando; Taeko Ogawa; Mariko Muta; Carsten Hornig; Herbert A Weich
Journal:  Int J Cancer       Date:  2002-03-01       Impact factor: 7.396

6.  Novel particulate spin probe for targeted determination of oxygen in cells and tissues.

Authors:  Ramasamy P Pandian; Narasimham L Parinandi; Govindasamy Ilangovan; Jay L Zweier; Periannan Kuppusamy
Journal:  Free Radic Biol Med       Date:  2003-11-01       Impact factor: 7.376

7.  Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.

Authors:  Elaine Y Lin; Joan G Jones; Ping Li; Liyin Zhu; Kathleen D Whitney; William J Muller; Jeffrey W Pollard
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

8.  M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes.

Authors:  Tim D Eubank; Michelle Galloway; Christine M Montague; W James Waldman; Clay B Marsh
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

Review 9.  The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update.

Authors:  Eva Sapi
Journal:  Exp Biol Med (Maywood)       Date:  2004-01

10.  Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.

Authors:  E Y Lin; A V Nguyen; R G Russell; J W Pollard
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  76 in total

Review 1.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

2.  Cytokines in osteoblast-conditioned medium promote the migration of breast cancer cells.

Authors:  Xiaojia Chen; Jia Lu; Yuhua Ji; An Hong; Qiuling Xie
Journal:  Tumour Biol       Date:  2013-09-12

3.  The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

Authors:  Magda Stumpfova; Desirée Ratner; Edward B Desciak; Yehuda D Eliezri; David M Owens
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

4.  The Influence of Biomaterials on Cytokine Production in 3D Cultures.

Authors:  Mary C Regier; Sara I Montanez-Sauri; Michael P Schwartz; William L Murphy; David J Beebe; Kyung Eun Sung
Journal:  Biomacromolecules       Date:  2017-02-16       Impact factor: 6.988

5.  Transcription factor ets-2 plays an important role in the pathogenesis of pulmonary fibrosis.

Authors:  Christopher P Baran; Sara N Fischer; Gerard J Nuovo; Mohamed N Kabbout; Charles L Hitchcock; Benjamin D Bringardner; Sara McMaken; Christie A Newland; Carmen Z Cantemir-Stone; Gary S Phillips; Michael C Ostrowski; Clay B Marsh
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

6.  Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

Authors:  Saul J Priceman; James L Sung; Zory Shaposhnik; Jeremy B Burton; Antoni X Torres-Collado; Diana L Moughon; Mai Johnson; Aldons J Lusis; Donald A Cohen; M Luisa Iruela-Arispe; Lily Wu
Journal:  Blood       Date:  2009-12-11       Impact factor: 22.113

7.  Concurrent Longitudinal EPR Monitoring of Tissue Oxygenation, Acidosis, and Reducing Capacity in Mouse Xenograft Tumor Models.

Authors:  Andrey A Bobko; Jason Evans; Nicholas C Denko; Valery V Khramtsov
Journal:  Cell Biochem Biophys       Date:  2016-05-18       Impact factor: 2.194

8.  Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.

Authors:  Manli Song; Ting Liu; Changrong Shi; Xiangzhong Zhang; Xiaoyuan Chen
Journal:  ACS Nano       Date:  2015-12-14       Impact factor: 15.881

9.  Intermittent hypoxia exacerbates pancreatic β-cell dysfunction in a mouse model of diabetes mellitus.

Authors:  Shariq I Sherwani; Carolyn Aldana; Saif Usmani; Christopher Adin; Sainath Kotha; Mahmood Khan; Timothy Eubank; Philipp E Scherer; Narasimham Parinandi; Ulysses J Magalang
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

10.  Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model.

Authors:  Duan Chen; Julie M Roda; Clay B Marsh; Timothy D Eubank; Avner Friedman
Journal:  Bull Math Biol       Date:  2012-10-17       Impact factor: 1.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.